Philip Morris International (PM) Stock Overview
Operates as a tobacco company. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 4/6 |
PM Community Fair Values
Create NarrativeSee what 119 others think this stock is worth. Follow their fair value or set your own to get alerts.
Philip Morris International Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$184.33 |
| 52 Week High | US$185.16 |
| 52 Week Low | US$98.93 |
| Beta | 0.54 |
| 1 Month Change | 12.38% |
| 3 Month Change | 21.37% |
| 1 Year Change | 80.36% |
| 3 Year Change | 88.19% |
| 5 Year Change | 155.30% |
| Change since IPO | 273.21% |
Recent News & Updates
Is There An Opportunity With Philip Morris International Inc.'s (NYSE:PM) 28% Undervaluation?
May 31
Phillip Morris's Undeniable Market Leadership Comes At Too Great A Cost
May 29Philip Morris International's (NYSE:PM) Returns On Capital Not Reflecting Well On The Business
May 13Philip Morris Torches Analyst Estimates, Attractive Long-Term Upside Ahead
Apr 29Recent updates
Is There An Opportunity With Philip Morris International Inc.'s (NYSE:PM) 28% Undervaluation?
May 31Phillip Morris's Undeniable Market Leadership Comes At Too Great A Cost
May 29Philip Morris International's (NYSE:PM) Returns On Capital Not Reflecting Well On The Business
May 13Philip Morris Torches Analyst Estimates, Attractive Long-Term Upside Ahead
Apr 29Philip Morris International Inc. Just Recorded A 9.1% EPS Beat: Here's What Analysts Are Forecasting Next
Apr 25Philip Morris Q1 Preview: Top Recession Stock
Apr 21
IQOS And ZYN Will Face Regulatory Challenges Yet Create Opportunities
Regulatory hurdles and slow new market entries could hinder growth for smoke-free products like IQOS and ZYN.IQOS, ZYN And VEEV Expansion Will Transform Smoke-Free Markets
Expansion of smoke-free products like IQOS and ZYN enhances revenue potential and operating margins through scalable profitability and market share growth.Philip Morris: Outpacing The Market, With More Room To Run
Mar 28Getting In Cheap On Philip Morris International Inc. (NYSE:PM) Might Be Difficult
Mar 21Philip Morris International: Business Evolution And The Bet On Smoke-Free Products
Mar 18Philip Morris Rally Is Well Deserved - Upgrade To Buy At Dips
Mar 12Philip Morris: Wall Street Buy Rating Vs. Insider Sales
Mar 04Philip Morris: No Margin Of Safety
Feb 10Philip Morris: Fairly Priced Into Earnings, But A Very Strong Chart
Feb 03Philip Morris International (NYSE:PM) May Have Issues Allocating Its Capital
Jan 21Philip Morris Continues To Be A Top Dividend Idea Yielding Around 4.5%
Jan 02Investors Interested In Philip Morris International Inc.'s (NYSE:PM) Earnings
Dec 16Philip Morris Continues To Reward Shareholders
Dec 02Philip Morris International Inc.'s (NYSE:PM) Intrinsic Value Is Potentially 86% Above Its Share Price
Nov 28Philip Morris: Market Dominance In Smoke-Free Products Driving A Compelling Growth Story
Nov 24Philip Morris: King Of The Tobacco Jungle - Minimal Upside/ Dividends Here
Oct 29Philip Morris International Pops; Yield Drops
Oct 23Building A Portfolio Of Leaders With Philip Morris
Oct 15Philip Morris International (NYSE:PM) May Have Issues Allocating Its Capital
Oct 05Innovation Titan Philip Morris International Comes To America
Sep 23Philip Morris: Strong Cash Flow At A Lower Valuation
Sep 09Earnings Not Telling The Story For Philip Morris International Inc. (NYSE:PM)
Aug 30Philip Morris' Stock Is Going Up, So Will Its Dividend
Aug 24Philip Morris: 5% Yield Is Now Too Expensive (Rating Downgrade)
Jul 30Philip Morris International Conquers The Ever-Changing World
Jul 23Are Investors Undervaluing Philip Morris International Inc. (NYSE:PM) By 40%?
Jul 22Philip Morris: Expanding EPS And Dividend Growth Make This A Winner, Yielding Over 5%
Jul 05Investors Could Be Concerned With Philip Morris International's (NYSE:PM) Returns On Capital
Jul 045% Yield: Philip Morris Is A Smokin' Deal In A Tricky Market
Jun 21Philip Morris: Undervalued Growth Stock At An Inflection Point
Jun 03Philip Morris International: The Smoke-Free Future Is Now Here
May 17Philip Morris: Big Nicotine Winner Rarely Comes Cheap
May 09Philip Morris Yields 6% But Faces Credit Downgrade Risk
Apr 16Philip Morris: A Top Income Stock With A 6% Yield
Apr 10Philip Morris International: Buy This High-Yielding Stock
Mar 14Philip Morris: Best Of Breed As 2024/2025 Brings New Tailwinds
Feb 21Shareholder Returns
| PM | US Tobacco | US Market | |
|---|---|---|---|
| 7D | 1.4% | -0.3% | -0.6% |
| 1Y | 80.4% | 29.7% | 10.6% |
Return vs Industry: PM exceeded the US Tobacco industry which returned 29.7% over the past year.
Return vs Market: PM exceeded the US Market which returned 10.6% over the past year.
Price Volatility
| PM volatility | |
|---|---|
| PM Average Weekly Movement | 3.5% |
| Tobacco Industry Average Movement | 8.3% |
| Market Average Movement | 7.7% |
| 10% most volatile stocks in US Market | 17.3% |
| 10% least volatile stocks in US Market | 4.0% |
Stable Share Price: PM has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: PM's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 83,100 | Jacek Olczak | www.pmi.com |
Philip Morris International Inc. operates as a tobacco company. The company offers cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products under the IQOS and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness and healthcare products.
Philip Morris International Inc. Fundamentals Summary
| PM fundamental statistics | |
|---|---|
| Market cap | US$286.55b |
| Earnings (TTM) | US$7.57b |
| Revenue (TTM) | US$38.39b |
Is PM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PM income statement (TTM) | |
|---|---|
| Revenue | US$38.39b |
| Cost of Revenue | US$13.17b |
| Gross Profit | US$25.21b |
| Other Expenses | US$17.64b |
| Earnings | US$7.57b |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Jul 22, 2025
| Earnings per share (EPS) | 4.87 |
| Gross Margin | 65.68% |
| Net Profit Margin | 19.73% |
| Debt/Equity Ratio | -555.3% |
How did PM perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/13 04:28 |
| End of Day Share Price | 2025/06/13 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Philip Morris International Inc. is covered by 44 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Coleman | Argus Research Company |
| Ishan Majumdar | Baptista Research |
| Michael Branca | Barclays |